Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
284.00    11.50 (4.22%)
Bid:
280.00
Ask:
288.00
Spread: 8.00 (2.857%)
Market Cap: £29.91m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

TVL Appoints Wates group

24 Feb 2026 07:00

RNS Number : 0776U
Alkemy Capital Investments PLC
24 February 2026
 

24 February 2026

 

Alkemy Capital Investments Plc

 

TVL Appoints Wates group to Advance Pre-Construction

 

Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) (JV2:FRA), announces that its wholly owned subsidiary Tees Valley Lithium ("TVL"), has agreed Heads of Terms with Wates Construction Limited ("Wates") for a Pre-Construction Services Agreement.

 

Further to the recently completed FEED study, a preferred project site in Teesside is being acquired. All core workstreams remain aligned to the previously announced timelines.

 

TVL's construction partner, Wates is one of the leading family-owned development, building and property maintenance companies. Over recent months, TVL and Wates have worked closely to align on delivery strategy, programme and execution approach.

 

Wates' appointment to progress pre-construction activities brings in relevant local industrial, construction and MEP experience from its Construction and SES divisions and strengthens the project's readiness as it transitions into execution.

 

HIGHLIGHTS

 

· FEED complete; timeline to FID, financing and development unchanged.

 

· Heads of Terms agreed with Wates for pre-construction activities.

 

· 17.2-acre (7 hectare) site at New Road, Billingham, Teesside being acquired; large enough to accommodate expansion up to 100ktpa production capacity.

 

· Pre-construction activities expected to commence early March 2026.

 

Alkemy Chairman Paul Atherley commented:

 

"We are pleased to be working with Wates as our construction partner, a highly experienced contractor with local connections. This agreement puts us in a strong position to draw on the many benefits of the Teesside region in the development of this world-class project." 

 

TVL CEO Vikki Jeckell commented:

 

"Working with Wates, an experienced Tier 1 contractor, represents a significant step forward for the project. Over recent months we have aligned on execution strategy, programme integration and delivery approach. 

 

"We are now transitioning into pre-construction execution. As we enter this phase, the project will be managed through a disciplined delivery framework focused on construction progression, procurement readiness and cost control.

"Alkemy will continue to update the market at appropriate project milestones as delivery progresses."

 

Wates Advanced Manufacturing MD Eddie Tribe commented:

 

"This is a positive milestone in the delivery of TVL's facility. We look forward to bringing our extensive experience in both construction and mechanical and electrical engineering to the project, to enable TVL to bring their vision to life."

 

Construction Progress

 

Under the Pre-Construction Services Agreement, which is expected to commence in March, Wates will work closely with the TVL team to progress the detailed engineering, construction planning, programme development and cost alignment required to prepare the project for construction.

 

Early contractor involvement at this stage enhances delivery readiness and provides greater certainty over scope, sequencing and procurement strategy.

 

Site Selection

 

The recently completed FEED studies evaluated a number of site options and compared leasing and purchasing structures. As a result, Alkemy has selected the 17.2-acre (7 hectare) New Road, Billingham, Teesside site for purchase as the preferred location.

 

Due to the site's location within an existing chemical park, which benefits from interconnecting services and utilities, no changes are necessary to the original plant design.

 

Wates Group: Established in 1897, Wates are one of the UK's leading family-owned development, building and property maintenance companies. In 2024, Wates generated underlying group profit before tax of £31.4m from a turnover of £2.40bn, working with a wide range of public and private-sector customers and partners. With 6,000 employees and now in their fourth generation of family ownership, they are committed to the long-term sustainability of the built environment and to making their industry more inclusive and representative of the communities they work in. Wates are an Investors in People Gold accredited company, driven by their purpose of reimagining places for people to thrive.  Wates.co.uk

 

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk).

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is dedicated to providing battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, TVL is committed to sustainable, efficient, and world-class operations.

 

 

Forward Looking Statements

 

This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFTFSIVFIR
Date   Source Headline
18th Dec 20237:00 amRNSOversubscribed Placing to raise £650,000
4th Dec 20237:00 amRNSTVL Secures Technology and Vendor Partnerships
20th Nov 20237:00 amRNSAppointment of Battery Metals Supply Chain Expert
13th Nov 20237:00 amRNSTVL First Feedstock Deal
1st Nov 202311:20 amRNSCorporate Presentation
31st Oct 202311:00 amRNSInvestor Webinar
27th Oct 20238:00 amRNSInterim Results for Period Ended 31 July 2023
24th Oct 20237:00 amRNSVSA lifts target price to £15.30 per share
3rd Oct 20237:00 amRNSUpdate on Lithium Feedstock and Offtake
29th Sep 20237:00 amRNSTVL Grant Funding Secured
23rd Aug 20238:00 amRNSFirst Lithium Sulphate Plant Study
1st Aug 202310:00 amRNSAustralia’s first Lithium Sulphate Plant
18th Jul 202311:00 amRNSResult of AGM
5th Jul 202311:00 amRNSAppointment of SI Capital as Corporate Broker
23rd Jun 202312:30 pmRNSNotice of Annual General Meeting
6th Jun 20234:00 pmRNSGrant of Options
31st May 20238:00 amRNS£1.35m Fundraise and Director Participation
31st May 20237:55 amRNSAnnual Report & Financial Statements
12th May 20238:00 amRNSMOU on process to unlock major Lithium feedstock
28th Apr 20238:00 amRNSTVL Management Recruitment
26th Apr 20238:00 amRNSMOU with Altilium Metals for lithium feedstock
20th Apr 20238:00 amRNSCorporate Update
17th Apr 20237:00 amRNSUK Minister Port Hedland Site Visit
31st Mar 20234:35 pmRNSPrice Monitoring Extension
31st Mar 20232:05 pmRNSSecond Price Monitoring Extn
31st Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20237:00 amRNSCMA highlights TVL’s strategic importance
1st Mar 20237:00 amRNSTVL Accelerates Lithium Supply With BritishVolt
7th Feb 20237:00 amRNSMOU with Recharge Industries
24th Jan 20237:00 amRNSFirst phase approval from the UK ATF
19th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSSite secured for Port Hedland Lithium plant
20th Dec 20227:00 amRNSLong Term Lease Agreed for TVL’s Lithium Facility
5th Dec 20229:00 amRNSCorporate Presentation
25th Nov 20227:00 amRNSApproval for Europe's biggest Lithium Plant
8th Nov 20227:00 amRNSAppointment of Lead Engineering Partner
27th Oct 20227:00 amRNSInterim Results
12th Oct 20229:30 amRNSTVL and bp trial Green Hydrogen
29th Sep 20227:00 amRNSCorporate Update
23rd Aug 20228:45 amRNSInitiation of Research Report by Shard Capital
15th Aug 20227:00 amRNSAgreement with Weardale Lithium
12th Aug 20225:00 pmRNSHolding(s) in Company
8th Aug 20223:20 pmRNSCorrection: Placing and Directors Purchase
8th Aug 20227:00 amRNSAustralia’s First Lithium Sulphate Plant
4th Aug 20228:00 amRNSGrant of Options
4th Aug 20227:00 amRNSOversubscribed Placing and Director Purchase
21st Jul 20227:00 amRNSLithium Feedstock Agreement with Traxys
20th Jul 20223:15 pmRNSResult of AGM
20th Jun 20227:00 amRNSInitiation of Research Coverage by VSA Capital
17th Jun 202212:00 pmRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.